Cargando…
Expression of inhibitory regulators of innate immunity in patients with active tuberculosis
BACKGROUND: Tuberculosis (TB) is an important cause of morbidity and mortality worldwide. Toll-like-receptors (TLRs) are important for the recognition of the causative agent Mycobacterium tuberculosis. Negative regulation of TLRs is necessary to control deleterious inflammatory damage, but could pro...
Autores principales: | Blok, Dana C, Kager, Liesbeth M, Hoogendijk, Arie J, Lede, Ivar O, Rahman, Wahid, Afroz, Rumana, Bresser, Paul, van der Zee, Jaring S, Ghose, Aniruddha, Visser, Caroline E, de Jong, Menno D, Zahed, Abu Shahed Md, Husain, Md Anwar, Alam, Khan Mashrequl, Barua, Pravat Chandra, Hassan, Mahtabuddin, Hossain, Ahmed, Tayab, Md Abu, Lutter, Rene, Day, Nick, Dondorp, Arjen M, de Vos, Alex F, van ’t Veer, Cornelis, van der Poll, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365962/ https://www.ncbi.nlm.nih.gov/pubmed/25887604 http://dx.doi.org/10.1186/s12879-015-0833-z |
Ejemplares similares
-
Neutrophil extracellular traps in patients with pulmonary tuberculosis
por: van der Meer, Anne Jan, et al.
Publicado: (2017) -
Pulmonary challenge with carbon nanoparticles induces a dose-dependent increase in circulating leukocytes in healthy males
por: Berger, Marieke, et al.
Publicado: (2017) -
Screening of novel alkaloid inhibitors for vascular endothelial growth factor in cancer cells: an integrated computational approach
por: Shahik, Shah Md., et al.
Publicado: (2021) -
Risk factors and actionable molecular signatures in COVID-19-associated lung adenocarcinoma and lung squamous cell carcinoma patients
por: Ullah, Md. Asad, et al.
Publicado: (2023) -
In silico assessment of EpCAM transcriptional expression and determination of the prognostic biomarker for human lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC)
por: Moin, Abu Tayab, et al.
Publicado: (2021)